| Parenteral Drugs (India) has reported a sales turnover of Rs 127.70 crore and a net profit of Rs 15.00 crore for the quarter ended Dec '10. | | For the quarter ended Dec 2009 the sales turnover was Rs 80.43 crore and net profit was Rs 6.25 crore. |
|
| | Quarterly Results of Parenteral Drugs (India) | -------- in Rs. Cr. -------- |
|
| Dec '09 | | | Sep '10 | Dec '10 | | Sales Turnover | 80.43 | | | 131.73 | 127.70 | | Other Income | -- | | | -- | -- | | Total Income | 80.43 | | | 131.73 | 127.70 | | Total Expenses | 67.37 | | | 104.54 | 101.19 | | Operating Profit | 13.06 | | | 27.19 | 26.51 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 13.06 | | | 27.19 | 26.51 | | Interest | 4.08 | | | 5.66 | 5.60 | | PBDT | 8.98 | | | 21.53 | 20.92 | | Depreciation | 1.45 | | | 1.97 | 1.97 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 7.53 | | | 19.56 | 18.95 | | Tax | 1.28 | | | 3.90 | 3.95 | | Net Profit | 6.25 | | | 15.66 | 15.00 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 3.22 | | | 6.05 | 5.80 | | Book Value | -- | | | -- | -- | | Equity | 19.40 | | | 25.87 | 25.87 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Religare Technova |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
